PWM
AMPH icon

Perigon Wealth Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Perigon Wealth Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,215
Closed -$229K – 867
2024
Q1 		$229K Sell
5,215
-6,887
-57% -$356K 0.01% 763
2023
Q4 		$749K Buy
12,102
+7,319
+153% +$384K 0.02% 408
2023
Q3 		$220K Buy
4,783
+12
+0.3% +$655 0.01% 702
2023
Q2 		$274K Sell
4,771
-3,279
-41% -$145K 0.01% 638
2023
Q1 		$302K Buy
8,050
+200
+3% +$6.56K 0.02% 535
2022
Q4 		$220K Hold
7,850
– – 0.01% 631
2022
Q3 		$221K Buy
+7,850
New +$256K 0.02% 511

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Perigon Wealth Management's AMPH Position: Q2 2024 in Review

Perigon Wealth Management sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2024, closing a stake of 5,215 shares — an estimated $229K sold.

Perigon Wealth Management first reported a position in AMPH in Q3 2022 and held it in 7 quarters. The position peaked at $749K in Q4 2023. 269 funds tracked by Wall St. Rank hold AMPH as of Q2 2024.

  • Perigon Wealth Management reported no remaining Amphastar Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Perigon Wealth Management sold 5,215 Amphastar Pharmaceuticals shares in Q2 2024, an estimated $229K.
  • Perigon Wealth Management first reported a position in Amphastar Pharmaceuticals in Q3 2022 and held it in 7 quarters.
  • Perigon Wealth Management's Amphastar Pharmaceuticals position peaked at $749K in Q4 2023.
  • 269 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2024.

Based on Perigon Wealth Management's 13F filing for Q2 2024, filed 2 Aug 2024.